| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Syndax Pharmaceuticals, Inc. (SNDX) has 3 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. SNDX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 484.8K | $9.33M | -6,847 | |
| CFO | 139.3K | $2.68M | -1,177 | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2023 | Goldan Keith A.53 | Chief Financial Officer | Sell | 577 | $22.31 | $12,872.87 | -18.0% | -22.2% | -9.1% | |
| Jun 9, 2023 | Morrison Briggs61 | Director | Sale+OE | 52,855 | $21.18 | $1,119,421.33 | -45.3% | -14.7% | -7.8% | |
| May 9, 2023 | Morrison Briggs61 | Director | Sale+OE | 52,855 | $21.41 | $1,131,477.56 | -74.8% | -14.5% | +3.5% | |
| Apr 10, 2023 | Morrison Briggs61 | Director | Sale+OE | 52,855 | $19.53 | $1,032,237.01 | -74.8% | +4.8% | +18.9% | |
| Mar 13, 2023 | Morrison Briggs61 | President, Head Of R&D | Sale+OE | 52,854 | $22.53 | $1,190,673.77 | -74.8% | -7.5% | +6.4% | |
| Feb 15, 2023 | Ordentlich Peter66 | Chief Scientific Officer | Sale+OE | 25,000 | $25.84 | $646,092.50 | -100% | -18.8% | -12.8% | |
| Feb 6, 2023 | Metzger Michael A52 | Chief Executive Officer | Sale+OE | 5,959 | $27.64 | $164,697.23 | -25.2% | -23.5% | -14.7% | |
| Feb 6, 2023 | Morrison Briggs61 | President, Head Of R&D | Sale+OE | 52,854 | $26.83 | $1,417,908.97 | -74.8% | -23.5% | -14.7% | |
| Feb 1, 2023 | Ordentlich Peter66 | Chief Scientific Officer | Sell | 69 | $28.43 | $1,961.54 | -100% | -31.7% | -26.7% | |
| Jan 13, 2023 | Legault Pierre61 | Director | Sale+OE | 39,000 | $26.84 | $1,046,781.60 | -28.9% | -23.2% | -15.5% |